{"altmetric_id":6475430,"counts":{"readers":{"mendeley":97,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["ElimRheumCtr"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["1068958376468387"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa5293cf058f610003ead","authors":["Barnes, Theresa C.","Barnes TC","Anderson ME","Moots RJ"],"doi":"10.1155\/2011\/721608","endpage":"6","first_seen_on":"2016-04-05T04:40:58+00:00","issns":["1687-9260","1687-9279"],"journal":"International Journal of Rheumatology","last_mentioned_on":1459831241,"links":["http:\/\/www.hindawi.com\/journals\/ijr\/2011\/721608\/"],"pdf_url":"http:\/\/downloads.hindawi.com\/journals\/ijr\/2011\/721608.pdf","pmcid":"PMC3176444","pmid":"21941555","pubdate":"2011-09-20T00:00:00+00:00","publisher":"Hindawi Publishing Corporation","startpage":"1","title":"The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis","type":"article","volume":"2011","mendeley_url":"http:\/\/www.mendeley.com\/research\/faces-interleukin6-role-il6-inflammation-vasculopathy-fibrosis-systemic-sclerosis"},"altmetric_score":{"score":0.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.75},"context_for_score":{"all":{"total_number_of_other_articles":7499955,"mean":6.4950193838481,"rank":5412520,"this_scored_higher_than_pct":24,"this_scored_higher_than":1823807,"rank_type":"exact","sample_size":7499955,"percentile":24},"similar_age_3m":{"total_number_of_other_articles":271808,"mean":11.189990846446,"rank":175685,"this_scored_higher_than_pct":29,"this_scored_higher_than":80689,"rank_type":"exact","sample_size":271808,"percentile":29},"this_journal":{"total_number_of_other_articles":64,"mean":2.5360317460317,"rank":38,"this_scored_higher_than_pct":35,"this_scored_higher_than":23,"rank_type":"exact","sample_size":64,"percentile":35},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":3,"Professor > Associate Professor":2,"Researcher":7,"Student  > Doctoral Student":7,"Student  > Ph. D. Student":37,"Student  > Postgraduate":4,"Student  > Master":14,"Other":6,"Student  > Bachelor":12,"Lecturer":3,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":33,"Mathematics":1,"Unspecified":5,"Environmental Science":1,"Pharmacology, Toxicology and Pharmaceutical Science":2,"Engineering":2,"Chemistry":3,"Neuroscience":1,"Immunology and Microbiology":8,"Agricultural and Biological Sciences":32,"Business, Management and Accounting":1,"Nursing and Health Professions":1,"Biochemistry, Genetics and Molecular Biology":7}}},"geo":{"twitter":{"SG":1},"mendeley":{"HU":1,"US":2,"DK":1,"MY":1,"MU":1,"DE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ElimRheumCtr\/statuses\/717210327469920256","license":"gnip","citation_ids":[6475430],"posted_on":"2016-04-05T04:40:41+00:00","author":{"name":"Dr Eugene Lim","url":"http:\/\/www.arthritis-rheumatism.com","image":"https:\/\/pbs.twimg.com\/profile_images\/673372820374597632\/dXGw7eYq_normal.jpg","description":"Centre for Autoimmunity & Rheumatology Excellence: Accessible Best Care Delivered Expeditiously!","id_on_source":"ElimRheumCtr","tweeter_id":"4435992492","geo":{"lt":1.36667,"ln":103.8,"country":"SG"},"followers":84},"tweet_id":"717210327469920256"}],"facebook":[{"title":"The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1146026172094940&id=1068958376468387","license":"public","citation_ids":[6475430],"posted_on":"2016-04-05T04:40:40+00:00","summary":"Scleroderma is possibly the most challenging autoimmune disease to treat, mainly because we still lack effective treatment tools for its fibrosing complications: especially in the skin and the lungs. Targeting IL6 looks promising.","author":{"name":"ELIM Rheumatic Centre","url":"https:\/\/www.facebook.com\/1068958376468387","facebook_wall_name":"ELIM Rheumatic Centre","image":"https:\/\/graph.facebook.com\/1068958376468387\/picture","id_on_source":"1068958376468387"}}]}}